Skip to content

City and County of San Francisco Department of Public Health Community Health Equity & Promotion Branch Population Health Division

Detox
Testing
Fertility
- Semen Volume increase pills to produce more cum and sperm
Living with HIV
About Us
News
- Long-Acting Cabotegravir And Rilpivirine Injections For HIV Treatment

Home » News » ADAPT-2

ADAPT-2

Posted bysfhiv

ADAPT-2 is a multi-site trial of bupropion plus extended-release naltrexone for adults with methamphetamine use disorder.

Author

sfhiv

View all posts

Posted bysfhivPosted inNews

Post navigation

Previous Post Previous post:
2011 Steering Committee

Next Post Next post:
Online Resources regarding specific drugs

SFHIV.ORG Copyright © 2023

Community Health Equity & Promotion Branch (CHEP) Population Health Division San Francisco Department of Public Health 25 Van Ness Avenue, Suite 500 San Francisco, CA 94102 Phone: 415. 437.6200
This site contains HIV prevention messages that may not be appropriate for all audiences. Since HIV infection is spread primarily through sexual practices or by sharing needles, prevention messages and programs presented on this website may address these topics. If you are not seeking such information or may be offended by such materials, please exit this website. All HIV prevention materials funded by CDC must be approved by local San Francisco program review panels.

Sitemap
Terms of Use
SFHIV cookies
SFHIV Legal Disclaimer